EA
PFE icon

Emerald Advisors’s Pfizer PFE Stock Holding History

Emerald Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,837
Closed -$220K – 130
2025
Q4 		$220K Sell
8,837
-2,708
-23% -$68.3K 0.03% 102
2025
Q3 		$294K Sell
11,545
-140
-1% -$3.46K 0.04% 90
2025
Q2 		$283K Sell
11,685
-19,938
-63% -$465K 0.04% 89
2025
Q1 		$801K Buy
31,623
+3,149
+11% +$82.4K 0.11% 47
2024
Q4 		$755K Buy
28,474
+2,190
+8% +$59.4K 0.1% 50
2024
Q3 		$768K Buy
26,284
+1,135
+5% +$33.1K 0.11% 47
2024
Q2 		$704K Buy
25,149
+5,544
+28% +$153K 0.11% 48
2024
Q1 		$544K Buy
19,605
+3,138
+19% +$87.1K 0.1% 57
2023
Q4 		$474K Sell
16,467
-4,140
-20% -$125K 0.09% 55
2023
Q3 		$684K Buy
20,607
+4,895
+31% +$173K 0.16% 37
2023
Q2 		$576K Buy
15,712
+1,443
+10% +$56.2K 0.14% 42
2023
Q1 		$582K Buy
14,269
+512
+4% +$22.1K 0.15% 39
2022
Q4 		$705K Sell
13,757
-665
-5% -$31.9K 0.2% 31
2022
Q3 		$631K Buy
14,422
+575
+4% +$27.9K 0.18% 36
2022
Q2 		$726K Buy
13,847
+682
+5% +$34.8K 0.2% 34
2022
Q1 		$682K Buy
13,165
+465
+4% +$24.1K 0.16% 36
2021
Q4 		$750K Buy
12,700
+1,750
+16% +$86.7K 0.18% 32
2021
Q3 		$471K Buy
10,950
+170
+2% +$7.53K 0.13% 59
2021
Q2 		$422K Buy
10,780
+688
+7% +$26.8K 0.13% 63
2021
Q1 		$366K Buy
10,092
+165
+2% +$5.86K 0.13% 57
2020
Q4 		$365K Sell
9,927
-2,563
-21% -$94K 0.13% 55
2020
Q3 		$435K Buy
12,490
+360
+3% +$12.6K 0.17% 44
2020
Q2 		$376K Sell
12,130
-348
-3% -$11.8K 0.17% 51
2020
Q1 		$441K Sell
12,478
-5,278
-30% -$180K 0.2% 37
2019
Q4 		$677K Buy
+17,756
New +$632K 0.65% 21

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Emerald Advisors's PFE Position: Q1 2026 in Review

Emerald Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 8,837 shares — an estimated $220K sold.

Emerald Advisors first reported a position in PFE in Q4 2019 and held it in 25 quarters. The position peaked at $801K in Q1 2025. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Emerald Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Emerald Advisors sold 8,837 Pfizer shares in Q1 2026, an estimated $220K.
  • Emerald Advisors first reported a position in Pfizer in Q4 2019 and held it in 25 quarters.
  • Emerald Advisors's Pfizer position peaked at $801K in Q1 2025.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Emerald Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.